PPP is a disabling and chronic condition marked by symptoms, such as anxiety, muscle weakness, pain, fatigue, and temporary paralysis.
FDA Extends Review of Omaveloxolone in Friedreich Ataxia
The Wide-Reaching Impact of Multiple Sclerosis DMT Wastes: Darin T. Okuda, MD; Karin Cook
Pepinemab’s Upregulation of SEMA4D Expression Warrants Further Development in Huntington, Alzheimer Disease
Future Relapse Remission in Multiple Sclerosis Impacted by Retinal Layer Thinning